About the event
Building on the momentum of our previous editions of the o2h ChaiTime Portfolio Pitch Day, we hosted the July 2025 session at our HQ in Cambridge. The format stayed the same; invited biotech investors and strategic partners, focused 10-minute pitches, five portfolio companies, and time for conversation and networking both in the room and online.
The July 2025 edition of the o2h ChaiTime Portfolio Pitch Day brought together founders, investors, and partners at Hauxton House in Cambridge for a focused afternoon of early-stage biotech innovation. The session featured pitches across oncology, AI-driven drug discovery, diagnostics, and metabolic health, reflecting the range of breakthrough science developing within the o2h Ventures portfolio. We heard from five CEOs building at the intersection of novel drug discovery and biotech enablement, with strong engagement from both the in-room and online audience.
Five portfolio CEOs presented their latest progress:
Tiffany Thorn, CEO, Bivictrix Tx
Peyman Gifani, CEO, AI VIVO
Patrick Beldon, CEO, Cortirio
Neil Torbett, CEO, PhoreMost
Dr Andrew Woodland, CEO, HawkHill Tx
This hybrid event brought together our global biotech network, with participation from investors, strategic partners, and representatives from the wider life sciences community who joined us at Hauxton House and via Zoom.
Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong.